graph Evidence gap map comparisons
neratinib based treatment
neratinib neratinib plus capecitabine
la/mBC - HER2 positive - 2nd Line (L2) 13      
Comparator:  vs placebo;   vs lapatinib plus capecitabine; 
Risk of bias:  low;   some concerns;   high;  NA;